Artificial Intelligence and Machine Learning in the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms-A Scoping Review.
GEP-NETs
Pan-NENs
SI-NETS
artificial intelligence
carcinoid
deep learning
gastroenteropancreatic
machine learning
neuroendocrine neoplasms
neuroendocrine tumors
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
31 Mar 2022
31 Mar 2022
Historique:
received:
27
02
2022
revised:
27
03
2022
accepted:
29
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Neuroendocrine neoplasms (NENs) and tumors (NETs) are rare neoplasms that may affect any part of the gastrointestinal system. In this scoping review, we attempt to map existing evidence on the role of artificial intelligence, machine learning and deep learning in the diagnosis and management of NENs of the gastrointestinal system. After implementation of inclusion and exclusion criteria, we retrieved 44 studies with 53 outcome analyses. We then classified the papers according to the type of studied NET (26 Pan-NETs, 59.1%; 3 metastatic liver NETs (6.8%), 2 small intestinal NETs, 4.5%; colorectal, rectal, non-specified gastroenteropancreatic and non-specified gastrointestinal NETs had from 1 study each, 2.3%). The most frequently used AI algorithms were Supporting Vector Classification/Machine (14 analyses, 29.8%), Convolutional Neural Network and Random Forest (10 analyses each, 21.3%), Random Forest (9 analyses, 19.1%), Logistic Regression (8 analyses, 17.0%), and Decision Tree (6 analyses, 12.8%). There was high heterogeneity on the description of the prediction model, structure of datasets, and performance metrics, whereas the majority of studies did not report any external validation set. Future studies should aim at incorporating a uniform structure in accordance with existing guidelines for purposes of reproducibility and research quality, which are prerequisites for integration into clinical practice.
Identifiants
pubmed: 35453922
pii: diagnostics12040874
doi: 10.3390/diagnostics12040874
pmc: PMC9027316
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Eur J Cancer. 2021 Sep;155:200-215
pubmed: 34391053
World J Gastrointest Oncol. 2020 Nov 15;12(11):1311-1324
pubmed: 33250963
Acad Radiol. 2020 Jan;27(1):62-70
pubmed: 31636002
Int J Comput Assist Radiol Surg. 2019 Nov;14(11):1981-1991
pubmed: 31555998
World J Gastroenterol. 2021 Jun 28;27(24):3543-3555
pubmed: 34239268
IEEE Trans Biomed Eng. 2014 Mar;61(3):859-70
pubmed: 24557687
IEEE J Biomed Health Inform. 2021 Sep;25(9):3498-3506
pubmed: 33798088
Med Image Comput Comput Assist Interv. 2013;16(Pt 1):436-43
pubmed: 24505696
NAR Cancer. 2020 Sep;2(3):zcaa009
pubmed: 32743554
Surg Clin North Am. 2020 Jun;100(3):635-648
pubmed: 32402306
Lasers Med Sci. 2016 Aug;31(6):1041-50
pubmed: 27147075
Cancers (Basel). 2021 May 27;13(11):
pubmed: 34072010
PLoS One. 2021 Jun 28;16(6):e0251701
pubmed: 34181680
Gastrointest Endosc. 2008 Dec;68(6):1086-94
pubmed: 18656186
JAMA Surg. 2020 Feb 1;155(2):148-158
pubmed: 31825465
J Ultrasound Med. 2010 Sep;29(9):1345-51
pubmed: 20733191
Artif Intell Med. 2007 May;40(1):45-55
pubmed: 17098402
Gastroenterology. 2005 May;128(6):1717-51
pubmed: 15887161
Ann Oncol. 2020 Jul;31(7):844-860
pubmed: 32272208
Endocr Relat Cancer. 2019 Jan 1;26(1):47-57
pubmed: 30021866
Nat Biomed Eng. 2018 Oct;2(10):719-731
pubmed: 31015651
Med Image Anal. 2014 Apr;18(3):555-66
pubmed: 24607911
Front Oncol. 2021 Jul 22;11:606677
pubmed: 34367940
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4002-4015
pubmed: 33835220
Biosci Rep. 2020 Jun 26;40(6):
pubmed: 32496505
Front Oncol. 2021 Jul 14;11:628408
pubmed: 34336643
Front Oncol. 2021 Sep 22;11:725988
pubmed: 34631555
J Med Internet Res. 2016 Dec 16;18(12):e323
pubmed: 27986644
Front Oncol. 2021 Feb 25;10:593211
pubmed: 33718106
Front Surg. 2021 Nov 03;8:745220
pubmed: 34805260
Neuroendocrinology. 2021;111(5):490-504
pubmed: 32392558
IEEE J Biomed Health Inform. 2021 Jul;25(7):2655-2664
pubmed: 33290235
Cancer. 2019 Apr 15;125(8):1247-1257
pubmed: 30620390
Orphanet J Rare Dis. 2020 Jun 9;15(1):145
pubmed: 32517778
Med Phys. 2021 Nov;48(11):7003-7015
pubmed: 34453332
Future Oncol. 2021 Aug;17(24):3217-3230
pubmed: 34008426
Diagnostics (Basel). 2021 May 12;11(5):
pubmed: 34065981
Med Image Comput Comput Assist Interv. 2016 Oct;9902:183-190
pubmed: 27924318
Cancers (Basel). 2021 May 31;13(11):
pubmed: 34072865
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
World J Gastroenterol. 2021 Jul 7;27(25):3734-3747
pubmed: 34321840
Front Oncol. 2021 Feb 11;10:521831
pubmed: 33643890
J Pathol Inform. 2020 Oct 09;11:32
pubmed: 33343993
Dig Dis Sci. 2018 Nov;63(11):3147-3152
pubmed: 30121810
Jpn J Radiol. 2020 Dec;38(12):1111-1124
pubmed: 33085029
JCO Clin Cancer Inform. 2020 Jul;4:666-679
pubmed: 32730116
World J Clin Cases. 2019 Jul 6;7(13):1611-1622
pubmed: 31367620
NPJ Digit Med. 2022 Jan 10;5(1):2
pubmed: 35013569
Eur J Clin Invest. 2015 Feb;45(2):204-14
pubmed: 25623047
IEEE Trans Med Imaging. 2016 Feb;35(2):550-66
pubmed: 26415167
Ann Transl Med. 2021 May;9(10):833
pubmed: 34164467
Neuroendocrinology. 2021;111(9):840-849
pubmed: 32721955
Diagnostics (Basel). 2021 Apr 28;11(5):
pubmed: 33925256
IEEE Trans Biomed Eng. 2019 Nov;66(11):3088-3097
pubmed: 30802845
J Cancer. 2018 Oct 10;9(21):3971-3978
pubmed: 30410601
Cancer. 2009 Apr 15;115(8):1638-50
pubmed: 19197975
EJNMMI Res. 2021 Oct 2;11(1):98
pubmed: 34601660
Neuroendocrinology. 2020;110(5):338-350
pubmed: 31525737
Med Image Comput Comput Assist Interv. 2015 Oct;9351:332-339
pubmed: 27924317
Sci Rep. 2020 Jul 6;10(1):11064
pubmed: 32632119
PLoS One. 2018 Apr 12;13(4):e0195621
pubmed: 29649302
Neuroendocrinology. 2020;110(6):444-476
pubmed: 31557758